The present invention relates to the field of tumour therapy, in particular to the identification of new molecules for tumour suppression, therapy and/or prevention, to compositions comprising the same and to medical treatments comprising administration of said compounds for the treatment, suppression and/or prevention of tumours. Furthermore, the present invention relates to inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours, to composition comprising inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours and to medical treatments comprising administering said inhibitors or compositions to a patient in need thereof, for the treatment, suppression and/or prevention of tumours.
De Maria Marchiano, R., Haas, T. L., Ricci Vitiani, L., Biffoni, M., Inhibitor of integrin for the treatment or prevention of tumours, 2013, Brevetto no. WO2014072940A1 [http://hdl.handle.net/10807/116774]
Inhibitor of integrin for the treatment or prevention of tumours
De Maria Marchiano, Ruggero;Haas, Tobias Longin;
2013
Abstract
The present invention relates to the field of tumour therapy, in particular to the identification of new molecules for tumour suppression, therapy and/or prevention, to compositions comprising the same and to medical treatments comprising administration of said compounds for the treatment, suppression and/or prevention of tumours. Furthermore, the present invention relates to inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours, to composition comprising inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours and to medical treatments comprising administering said inhibitors or compositions to a patient in need thereof, for the treatment, suppression and/or prevention of tumours.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
